Citigroup
BBNX icon

Citigroup’s Beta Bionics BBNX Stock Holding History

Citigroup’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$879K Sell
46,293
-27,762
-37% -$499K ﹤0.01% 3416
2026
Q2 		$1.16M Buy
74,055
+72,042
+3,579% +$857K ﹤0.01% 3334
2026
Q1 		$20.2K Buy
2,013
+69
+4% +$1.02K ﹤0.01% 4820
2025
Q4 		$59.2K Buy
1,944
+463
+31% +$12.4K ﹤0.01% 4511
2025
Q3 		$29.4K Sell
1,481
-3,124
-68% -$54.9K ﹤0.01% 4670
2025
Q2 		$67K Sell
4,605
-4,734
-51% -$67K ﹤0.01% 4618
2025
Q1 		$114K Buy
+9,339
New +$174K ﹤0.01% 4522

Other funds holding BBNX

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Values First Advisors
Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Evanson Financial
Evanson Financial Mclean, Virginia $2.03B AUM
Iams Wealth Management
Iams Wealth Management Omaha, Nebraska $342M AUM 13.91% 1-Year Est. Return
EverSource Wealth Advisors
EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Citigroup's BBNX Position: Q3 2026 in Review

Citigroup reduced its Beta Bionics (BBNX) stake by 37% in Q3 2026, selling an estimated $499K and leaving 46,293 shares worth $879K. The position accounts for ﹤0.01% of the portfolio, ranked #3416.

Citigroup first reported a position in BBNX in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.16M in Q2 2026. 35 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.

  • Citigroup held 46,293 shares of Beta Bionics worth $879K as of Q3 2026.
  • Citigroup sold 27,762 Beta Bionics shares in Q3 2026, an estimated $499K.
  • Beta Bionics made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #3416 holding.
  • Citigroup first reported a position in Beta Bionics in Q1 2025 and has held it in 7 quarters since.
  • Citigroup's Beta Bionics position peaked at $1.16M in Q2 2026.
  • 35 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.